Neurocrine Biosciences, Inc. is a company in the U.S. stock market and it is a holding in 73 U.S.-traded ETFs. NBIX has around 6.0M shares in the U.S. ETF market. The largest ETF holder of NBIX is the iShares NASDAQ Biotechnology ETF (IBB), with approximately 954.71K shares. Investors may also find of interest that the ETF with the largest allocation to NBIX stock is VanEck Vectors Biotech ETF (BBH), with a portfolio weight of 3.36%. On average, U.S. ETFs allocate 0.46% of NBIX to their portfolios.
Additionally, NBIX is a favorite stock for Vanilla and Growth ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with NBIX as a holding is the iShares Morningstar Mid-Cap Growth ETF (JKH), with a return of 26.51%.